Review ArticleNarrative Review

The Current State of Health Inequities in COPD

Jack Rea, Jay Tyler Babek, Reece M Anderson, Rigel Bacani, Jordan Staggs and Matt Vassar
Respiratory Care February 2024, 69 (2) 238-249; DOI: https://doi.org/10.4187/respcare.10553

REFERENCES

  1. 1.↵
    1. Baciu A,
    2. Negussie Y,
    3. et al
    National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Committee on Community-Based Solutions to Promote Health Equity, Baciu A, Negussie Y, et al. Summary. National Academies Press; 2017.
  2. 2.↵
    1. Ndugga N,
    2. Artiga S
    . Disparities in health and health care: 5 key questions and answers. KFF. https://www.kff.org/racial-equity-and-health-policy/issue-brief/disparities-in-health-and-health-care-5-key-question-and-answers/. Accessed June 28, 2022.
  3. 3.↵
    1. Blackman K,
    2. Garcia A,
    3. Nguyen K
    . Health disparities overview. https://www.ncsl.org/research/health/health-disparities-overview.aspx. Accessed June 28, 2022.
  4. 4.↵
    Chronic obstructive pulmonary disease (COPD). https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed June 28, 2022.
  5. 5.↵
  6. 6.↵
    1. Iheanacho I,
    2. Zhang S,
    3. King D,
    4. Rizzo M,
    5. Ismaila AS
    . Economic burden of chronic obstructive pulmonary disease (COPD): a systematic literature review. Int J Chron Obstruct Pulmon Dis 2020;15:439–460.
    OpenUrlPubMed
  7. 7.↵
    1. Criner RN,
    2. Han MK
    . COPD care in the 21st century: a public health priority. Respir Care 2018;63(5):591–600.
    OpenUrlAbstract/FREE Full Text
  8. 8.
    1. Hoogendoorn M,
    2. Feenstra TL,
    3. Asukai Y,
    4. Borg S,
    5. Hansen RN,
    6. Jansson S-A,
    7. et al
    . Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenarios. Value Health 2014;17(5):525–536.
    OpenUrlCrossRefPubMed
  9. 9.↵
    GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med 2017;5(9):691–706.
    OpenUrl
  10. 10.↵
    1. Ruvuna L,
    2. Sood A
    . Epidemiology of chronic obstructive pulmonary disease. Clin Chest Med 2020;41(3):315–327.
    OpenUrlCrossRefPubMed
  11. 11.
  12. 12.↵
    1. Duan R-R,
    2. Hao K,
    3. Yang T
    . Air pollution and chronic obstructive pulmonary disease. Chronic Dis Transl Med 2020;6(4):260–269.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. López-Campos JL,
    2. Tan W,
    3. Soriano JB
    . Global burden of COPD. Respirology 2016;21(1):14–23.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Maantay J
    . Zoning, equity, and public health. Am J Public Health 2001;91(7):1033–1041.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
  16. 16.↵
    1. Peters,
    2. Godfrey,
    3. McInerney,
    4. Munn
    . Chapter 11: scoping reviews (2020 version). JBI manual for evidence.
  17. 17.↵
    1. Tricco AC,
    2. Lillie E,
    3. Zarin W,
    4. O'Brien KK,
    5. Colquhoun H,
    6. Levac D,
    7. et al
    . PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 2018;169(7):467–473.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Anderson RM,
    2. Pena A,
    3. Dunford B,
    4. Brewer D,
    5. Garrett E,
    6. Staggs J,
    7. et al
    . OSF. https://osf.io/hmu4x/. Accessed July 5, 2022.
  19. 19.↵
    1. Bramer WM,
    2. Giustini D,
    3. Kramer BMR
    . Comparing the coverage, recall, and precision of searches for 120 systematic reviews in Embase, MEDLINE, and Google Scholar: a prospective study. Syst Rev 2016;5:39.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Feit NZ,
    2. Wang Z,
    3. Demetres MR,
    4. Drenis S,
    5. Andreadis K,
    6. Rameau A
    . Healthcare disparities in laryngology: a scoping review. Laryngoscope 2022;132(2):375–390.
    OpenUrlCrossRefPubMed
  21. 21.↵
    Overview. NIMHD. https://www.nimhd.nih.gov/about/overview/. Accessed July 7, 2022.
  22. 22.↵
    Officer CE. Scoping reviews: what they are and how you can do them. https://training.cochrane.org/resource/scoping-reviews-what-they-are-and-how-you-can-do-them. Accessed July 6, 2022.
  23. 23.↵
    1. Ouzzani M,
    2. Hammady H,
    3. Fedorowicz Z,
    4. Elmagarmid A
    . Rayyan–a web and mobile app for systematic reviews. Syst Rev 2016;5(1):210.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Shanaa A
    . Rayyan – intelligent systematic review. Rayyan. https://rayyan.qcri.org/. Accessed June 27, 2022.
  25. 25.↵
    1. Balk EM,
    2. Chung M,
    3. Hadar N,
    4. Patel K,
    5. Yu WW,
    6. Trikalinos TA,
    7. et al
    . Accuracy of data extraction of non-English language trials with Google Translate. Rockville (Maryland): Agency for Healthcare Research and Quality (US); 2012.
  26. 26.↵
    1. Nussbaumer-Streit B,
    2. Klerings I,
    3. Dobrescu AI,
    4. Persad E,
    5. Stevens A,
    6. Garritty C,
    7. et al
    . Excluding non-English publications from evidence-syntheses did not change conclusions: a meta-epidemiological study. J Clin Epidemiol 2020;118:42–54.
    OpenUrlCrossRefPubMed
  27. 27.↵
    National Institutes of Health. Minority Health and Health Disparities Strategic Plan 2021–2025. Bethesda, Maryland: National Institutes of Health, 2021.
  28. 28.↵
    Association AM, Others. Advancing health equity: a guide to language, narrative and concepts
  29. 29.↵
    1. Kuhn BT,
    2. Wick KD,
    3. Schivo M
    . An update in health disparities in COPD in the USA. Curr Pulmonol Rep 2021;10(1):14–21.
    OpenUrl
  30. 30.↵
    1. Pleasants RA,
    2. Riley IL,
    3. Mannino DM
    . Defining and targeting health disparities in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2016;11:2475–2496.
    OpenUrlPubMed
  31. 31.↵
    1. Cichowitz C,
    2. Loevinsohn G,
    3. Klein EY,
    4. Colantuoni E,
    5. Galiatsatos P,
    6. Rennert J,
    7. Irvin NA
    . Racial and ethnic disparities in hospital observation in Maryland. Am J Emerg Med 2021;46:532–538.
    OpenUrl
  32. 32.↵
    1. Spitzer KA,
    2. Stefan MS,
    3. Priya A,
    4. Pack QR,
    5. Pekow PS,
    6. Lagu T,
    7. et al
    . Participation in pulmonary rehabilitation after hospitalization for chronic obstructive pulmonary disease among Medicare beneficiaries. Ann Am Thorac Soc 2019;16(1):99–106.
    OpenUrl
  33. 33.↵
    1. Lowe KE,
    2. Make BJ,
    3. Crapo JD,
    4. Kinney GL,
    5. Hokanson JE,
    6. Kim V,
    7. et al
    . Association of low income with pulmonary disease progression in smokers with and without chronic obstructive pulmonary disease. ERJ Open Res 2018;4(4):00069-2018.
  34. 34.↵
    1. Gaffney AW,
    2. Hawks L,
    3. Bor D,
    4. White AC,
    5. Woolhandler S,
    6. McCormick D,
    7. Himmelstein DU
    . National trends and disparities in health care access and coverage among adults with asthma and COPD: 1997–2018. Chest 2021;159(6):2173–2182.
    OpenUrl
  35. 35.↵
    1. Croft JB,
    2. Lu H,
    3. Zhang X,
    4. Holt JB
    . Geographic accessibility of pulmonologists for adults with COPD: United States, 2013. Chest 2016;150(3):544–553.
    OpenUrl
  36. 36.↵
    1. Spitzer KA,
    2. Stefan MS,
    3. Priya A,
    4. Pack QR,
    5. Pekow PS,
    6. Lagu T,
    7. et al
    . A geographic analysis of racial disparities in use of pulmonary rehabilitation after hospitalization for COPD exacerbation. Chest 2020;157(5):1130–1137.
    OpenUrl
  37. 37.↵
    1. Moscovice IS,
    2. Casey MM,
    3. Wu Z
    . Disparities in geographic access to hospital outpatient pulmonary rehabilitation programs in the United States. Chest 2019;156(2):308–315.
    OpenUrl
  38. 38.↵
    1. Raghavan D,
    2. Varkey A,
    3. Bartter T
    . Chronic obstructive pulmonary disease: the impact of gender. Curr Opin Pulm Med 2017;23(2):117–123.
    OpenUrl
  39. 39.↵
    1. Haynes JM,
    2. Stumbo RW
    . The impact of using non-birth sex on the interpretation of spirometry data in subjects with air-flow obstruction. Respir Care 2018;63(2):215–218.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Jørgensen IF,
    2. Brunak S
    . Time-ordered comorbidity correlations identify patients at risk of mis- and overdiagnosis. NPJ Digit Med 2021;4(1):12.
    OpenUrl
  41. 41.↵
    1. Hangaard S,
    2. Helle T,
    3. Nielsen C,
    4. Hejlesen OK
    . Causes of misdiagnosis of chronic obstructive pulmonary disease: a systematic scoping review. Respir Med 2017;129:63–84.
    OpenUrl
  42. 42.↵
    1. Bhakta NR,
    2. Bime C,
    3. Kaminsky DA,
    4. McCormack MC,
    5. Thakur N,
    6. Stanojevic S,
    7. et al
    . Race and ethnicity in pulmonary function test interpretation: an official American Thoracic Society statement. Am J Respir Crit Care Med 2023;207(8):978–995.
    OpenUrlCrossRef
  43. 43.↵
    1. Miller MR,
    2. Graham BL,
    3. Thompson BR
    . Race/ethnicity and reference equations for spirometry. Am J Respir Crit Care Med 2022;206(6):790–792.
    OpenUrl
  44. 44.↵
    1. Arigliani M,
    2. Stanojevic S
    . The challenges of using race- and ethnicity-based spirometry reference equations in genetically admixed populations. Chest 2022;162(1):11–13.
    OpenUrl
  45. 45.↵
    1. Marciniuk DD,
    2. Becker EA,
    3. Kaminsky DA,
    4. McCormack MC,
    5. Stanojevic S,
    6. Bhakta NR,
    7. et al
    . Effect of race and ethnicity on pulmonary function testing interpretation: An American College of Chest Physicians (CHEST), American Association for Respiratory Care (AARC), American Thoracic Society (ATS), and Canadian Thoracic Society (CTS) evidence review and research statement. Chest 2023;164(2):461–475.
    OpenUrl
  46. 46.↵
    1. Connolly D,
    2. Hughes X,
    3. Berner A
    . Barriers and facilitators to cervical cancer screening among transgender men and non-binary people with a cervix: a systematic narrative review. Prev Med 2020;135:106071.
    OpenUrlPubMed
  47. 47.↵
    1. Foer D,
    2. Rubins D,
    3. Almazan A,
    4. Wickner PG,
    5. Bates DW,
    6. Hamnvik O-PR
    . Gender reference use in spirometry for transgender patients. Ann Am Thorac Soc 2021;18(3):537–540.
    OpenUrl
  48. 48.↵
    CDCTobaccoFree. LGBTQ+ people and commercial tobacco: Health disparities and ways to advance Health equity. Centers for Disease Control and Prevention. https://www.cdc.gov/tobacco/health-equity/lgbtq/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Ftobacco%2Fdisparities%2Flgbt%2Findex.htm. Accessed June 25, 2023.
  49. 49.↵
    1. Mirbolouk M,
    2. Charkhchi P,
    3. Kianoush S,
    4. Uddin SMI,
    5. Orimoloye OA,
    6. Jaber R,
    7. et al
    . Prevalence and distribution of e-cigarette use among U.S. adults: behavioral risk factor surveillance system, 2016. Ann Intern Med 2018;169(7):429–438.
    OpenUrlCrossRefPubMed
  50. 50.↵
    1. Strang JF,
    2. Klomp SE,
    3. Caplan R,
    4. Griffin AD,
    5. Anthony LG,
    6. Harris MC,
    7. et al
    . Community-based participatory design for research that impacts the lives of transgender and/or gender-diverse autistic and/or neurodiverse people. Clin Pract Pediatr Psychol 2019;7(4):396–404.
    OpenUrl
  51. 51.↵
    COPDGene. http://www.copdgene.org/. Accessed July 24, 2022.
  52. 52.↵
    1. Ejike CO,
    2. Dransfield MT,
    3. Hansel NN,
    4. Putcha N,
    5. Raju S,
    6. Martinez CH,
    7. Han MK
    . Chronic obstructive pulmonary disease in America's black population. Am J Respir Crit Care Med 2019;200(4):423–430.
    OpenUrl
  53. 53.↵
    1. Taylor DR,
    2. Kinney CD,
    3. McDevitt DG
    . Patient compliance with oral theophylline therapy. Br J Clin Pharmacol 1984;17(1):15–20.
    OpenUrlCrossRefPubMedWeb of Science
  54. 54.↵
    1. Bosley CM,
    2. Corden ZM,
    3. Rees PJ,
    4. Cochrane GM
    . Psychological factors associated with use of home nebulized therapy for COPD. Eur Respir J 1996;9(11):2346–2350.
    OpenUrlAbstract/FREE Full Text
  55. 55.↵
    1. Bryant J,
    2. McDonald VM,
    3. Boyes A,
    4. Sanson-Fisher R,
    5. Paul C,
    6. Melville J
    . Improving medication adherence in chronic obstructive pulmonary disease: a systematic review. Respir Res 2013;14(1):109.
    OpenUrlCrossRefPubMed
  56. 56.↵
    1. Velasquez AJ,
    2. Douglas JA,
    3. Guo F,
    4. Robinette JW
    . In the eyes of the beholder: race, place and health. Front Public Health 2022;10:920637.
    OpenUrl
  57. 57.↵
    1. Egede LE,
    2. Walker RJ,
    3. Campbell JA,
    4. Linde S,
    5. Hawks LC,
    6. Burgess KM
    . Modern day consequences of historic redlining: finding a path forward. J Gen Intern Med 2023;38(6):1534–1537.
    OpenUrl
  58. 58.
    1. Oh DL,
    2. Sarafian F,
    3. Silvestre A,
    4. Brown T,
    5. Jacobson L,
    6. Badri S,
    7. Detels R
    . Evaluation of adherence and factors affecting adherence to combination antiretroviral therapy among White, Hispanic, and Black men in the MACS Cohort. J Acquir Immune Defic Syndr 2009;52(2):290–293.
    OpenUrlCrossRefPubMedWeb of Science
  59. 59.↵
    1. Rolnick SJ,
    2. Pawloski PA,
    3. Hedblom BD,
    4. Asche SE,
    5. Bruzek RJ
    . Patient characteristics associated with medication adherence. Clin Med Res 2013;11(2):54–65.
    OpenUrlAbstract/FREE Full Text
  60. 60.↵
    1. Díaz AA,
    2. Celli B,
    3. Celedón JC
    . Chronic obstructive pulmonary disease in Hispanics. A 9-year update. Am J Respir Crit Care Med 2018;197(1):15–21.
    OpenUrl
  61. 61.↵
    1. Shimoda M,
    2. Takao S,
    3. Kokutou H,
    4. Yoshida N,
    5. Fujiwara K,
    6. Furuuchi K,
    7. et al
    . In-hospital pulmonary rehabilitation after completion of primary respiratory disease treatment improves physical activity and ADL performance: a prospective intervention study. Medicine (Baltimore) 2021;100(49):e28151.
    OpenUrl
  62. 62.↵
    1. Lahham A,
    2. Holland AE
    . The need for expanding pulmonary rehabilitation services. Life (Basel) 2021;11(11):1236.
    OpenUrl
  63. 63.↵
    1. Tsutsui M,
    2. Gerayeli F,
    3. Sin DD
    . Pulmonary rehabilitation in a post-COVID-19 world: telerehabilitation as a new standard in patients with COPD. Int J Chron Obstruct Pulmon Dis 2021;16:379–391.
    OpenUrlPubMed
  64. 64.↵
    1. Higgins JPT,
    2. Thomas J,
    3. Chandler J,
    4. Cumpston M,
    5. Li T,
    6. Page MJ,
    7. et al
    . Cochrane Handbook for Systematic Reviews of Interventions: John Wiley & Sons; 2019.
  65. 65.↵
    Overview. NIMHD. https://www.nimhd.nih.gov/about/overview/. Accessed March 10, 2023.
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...

Keywords